HistoGeneX (Belgium)

Recent papers from HistoGeneX (Belgium)

1. Selective Clearance of Macrophages in Atherosclerotic Plaques by AutophagyJournal of the American College of Cardiology · 2007
2. In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived ProbesFrontiers in Chemistry · 2021
3. A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with PembrolizumabCancers · 2021
4. Vanucizumab mode of action: Serial biomarkers in plasma, tumor, and skin-wound-healing biopsiesTranslational Oncology · 2020
5. Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to ArmsJCO Global Oncology · 2020
6. Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathyBritish Journal of Cancer · 2020
7. PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different PrognosisCancers · 2020
8. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trialsnpj Breast Cancer · 2020
9. Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate CancerCancer Immunology Research · 2020
10. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic valueThe Journal of Pathology Clinical Research · 2020
11. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practiceThe Journal of Pathology · 2020
12. HER-2 status of circulating tumor cells in a metastatic breast cancer cohort: A comparative study on characterization techniquesPLoS ONE · 2019
13. Rapid clinical mutational testing of KRAS, BRAF and EGFR: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencingJournal of Clinical Pathology · 2019
14. Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expressionBreast Cancer Research · 2019
15. Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)Proceedings of the National Academy of Sciences · 2018
16. TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate CancerClinical Cancer Research · 2018
17. Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastasesThe Journal of Pathology Clinical Research · 2018
18. Consensus guidelines for the use and interpretation of angiogenesis assaysAngiogenesis · 2018
19. Optimal Evaluation of Programmed Death Ligand-1 on Tumor Cells Versus Immune Cells Requires Different Detection MethodsArchives of Pathology & Laboratory Medicine · 2018
20. Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathologyAlzheimer s Research & Therapy · 2018